01.08.2016 • NewsElaine BurridgeCelaneseamines

Celanese Stops Mexican Amines Production

Following a business review, US technology and specialty materials company Celanese has decided to stop production, storage and distribution of monomethylamine (MMA) at Cangrejera, Mexico, saying the business is no longer viable. The decision applies to both anhydrous and 50% solution grades of MMA.

The Dallas, Texas-headquartered company said the site will continue to make dimethylamine (DMA) and trimethylamine (TMA) with a focus on growing and expanding its amines business, along with other key acetyl products manufactured at the site. Monomethylamine production equipment at Cangrejera has been converted to exclusively produce DMA and TMA.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read